Quantum Biopharma (QNTM) Short-term Investments (2019 - 2026)

Quantum Biopharma (QNTM) has 8 years of Short-term Investments data on file, last reported at $222906.0 in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments rose 968.17% year-over-year to $222906.0; the trailing twelve-month figure through Mar 2026 stood at $222906.0 (up 968.17% YoY), and the FY2025 full-year result was $459080.0, down 61.82% from the prior year.
• Short-term Investments declined to $222906.0 in Q1 2026, from $459080.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $3.5 million in Q3 2024 to a low of $20868.0 in Q1 2025.
• A 5-year average of $663517.0 and a median of $499641.5 in 2022 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments sank 96.02% in 2024 and soared 968.17% in 2026, its largest moves.
• Tracing QNTM's Short-term Investments over 5 years: stood at $365092.0 in 2022, then surged by 102.58% to $739600.0 in 2023, then soared by 62.57% to $1.2 million in 2024, then plunged by 61.82% to $459080.0 in 2025, then plunged by 51.45% to $222906.0 in 2026.
• Business Quant data shows QNTM's Short-term Investments at $222906.0 in Q1 2026, $459080.0 in Q4 2025, and $636761.0 in Q3 2025.